You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 8,697,711


✉ Email this page to a colleague

« Back to Dashboard


Title:Inhibitors of bruton'S tyrosine kinase
Abstract: Disclosed herein are compounds, including compounds having the structure of Formula (A), (B), (C), and (D), as described in further detail herein, that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
Inventor(s): Honigberg; Lee (San Francisco, CA), Verner; Erik (Belmont, CA), Pan; Zhengying (Austin, TX)
Assignee: Pharmacyclics, Inc. (Sunnyvale, CA)
Filing Date:May 23, 2012
Application Number:13/479,053
Claims:1. A compound having the structure: ##STR00057##

2. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound having the structure: ##STR00058##

3. A compound having the structure: ##STR00059##

4. A pharmaceutical composition comprising a compound of claim 3 and a pharmaceutically acceptable excipient.

5. A process for the preparation of (R)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3, R-isomer) comprising coupling of intermediate 2 and (S)-tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00060## under Mitsunobu reaction conditions to give intermediate 3 (R-isomer): ##STR00061##

6. The process of claim 5, wherein the process comprises coupling of intermediate 2 and (S)-tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

7. A process for the preparation of (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pi- peri-din-1-yl)prop-2-en-1-one (compound 13) comprising treating intermediate 3 (R-isomer) of claim 5 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 13: ##STR00062##

8. A process for the preparation of (S)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3, S-isomer) comprising coupling of intermediate 2 and (R)-tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00063## under Mitsunobu reaction conditions to give intermediate 3 (S-isomer): ##STR00064##

9. The process of claim 8, wherein the Mitsunobu reaction conditions comprises coupling of intermediate 2 and (R)-tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

10. A process for the preparation of (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pi- peri-din-1-yl)prop-2-en-1-one (compound 14) comprising treating intermediate 3 (S-isomer) of claim 8 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 14: ##STR00065##

11. A process for the preparation of tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- e-1-carboxylate (intermediate 3) comprising coupling of intermediate 2 and tert-butyl 3-hydroxypiperidine-1-carboxylate: ##STR00066## under Mitsunobu reaction conditions to give intermediate 3: ##STR00067##

12. The process of claim 11, wherein the Mitsunobu reaction conditions comprises coupling of intermediate 2 and tert-butyl 3-hydroxypiperidine-1-carboxylate in the presence of diisopropyl azodicarboxylate and polymer-bound triphenylphosphine in tetrahydrofuran.

13. A process for the preparation of 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperi- -din-1-yl)prop-2-en-1-one (compound 4) comprising treating intermediate 3 of claim 11 with an acid and then a base, followed by coupling with acryloyl chloride to give compound 4: ##STR00068##

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.